PROTRITAC
"PROTRITAC" is a word mark owned by Harpoon Therapeutics, Inc., filed at the USPTO on October 22, 2026. It is under examination and covers classes 5 and 42.
- Status
- Under examination
- Since October 22, 2026
- Filed
- October 22, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50176287
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns PROTRITAC
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Harpoon Therapeutics, Inc.
Rahway, United States
Representative
Lisa M. Dellamura
Merck & Co., Inc.
What the mark covers
The products and services PROTRITAC is filed for, grouped by Nice class.
Pharmaceutical preparations for T Cell therapy; Pharmaceutical preparations for the treatment of cancer and tumors; Biological preparations for the treatment of cancer and tumors; biotechnological platform technology, namely, biotechnological, diagnostic, and therapeutic preparations in the form of antibodies for delivery to cells in T cell therapy and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors
Pharmaceutical research and development
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About PROTRITAC
Who owns the trademark "PROTRITAC"?
The USPTO trademark "PROTRITAC" (application 50176287) is owned by Harpoon Therapeutics, Inc.
What is the status of "PROTRITAC"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull PROTRITAC and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a168de-36ac-73f8-af4c-3193caf32dd7
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a168de-36ac-73f8-af4c-3193caf32dd7",
"object": "trademark",
"mark_text": "PROTRITAC",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50176287",
"filing_date": "2026-10-22",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "Harpoon Therapeutics, Inc.",
"entity_id": "ent_019eb70a-d086-7481-888b-9764dcd68d7f"
}
]
}